Xingxing S Cheng
Biographic Data
| ID | 5541331 |
|---|---|
| NAME | Xingxing S Cheng |
| GIVEN NAMES | Xingxing S |
| FAMILY NAME | Cheng |
| SIGNATURE | CHENG X S |
| AFFILIATIONS | Department of Medicine, Division of Nephrology, Stanford University School of Medicine, Palo Alto, CA |
| ORCID | 0000-0002-0542-8749 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Calcimimetic Prescriptions in Fee-for-Service Medicare Beneficiaries Undergoing Dialysis
The results of this longitudinal cohort study showed that after transitioning calcimimetic coverage from Part D to Part B via TDAPA, calcimimetic prescriptions increased in a graded manner, with the largest increases experienced by patients previously subject to the highest out-of-pocket prescription drug costs. Medicare's TDAPA policy has the potential to expand access to medications for patients
The Medical Costs of Determining Eligibility and Waiting for a Kidney Transplantation
BACKGROUND: Recent efforts to increase access to kidney transplant (KTx) in the United States include increasing referrals to transplant programs, leading to more pretransplant services. Transplant programs reconcile the costs of these services through the Organ Acquisition Cost Center (OACC). OBJECTIVE: The aim of this study was to determine the costs associated with pretransplant services by applying microeconomic methods to OACC costs reported…
No prominent works on this page.
The Medical Costs of Determining Eligibility and Waiting for a Kidney Transplantation
BACKGROUND: Recent efforts to increase access to kidney transplant (KTx) in the United States include increasing referrals to transplant programs, leading to more pretransplant services. Transplant programs reconcile the costs of these services through the Organ Acquisition Cost Center (OACC). OBJECTIVE: The aim of this study was to determine the costs associated with pretransplant services by applying microeconomic methods to OACC costs reported…
Calcimimetic Prescriptions in Fee-for-Service Medicare Beneficiaries Undergoing Dialysis
The results of this longitudinal cohort study showed that after transitioning calcimimetic coverage from Part D to Part B via TDAPA, calcimimetic prescriptions increased in a graded manner, with the largest increases experienced by patients previously subject to the highest out-of-pocket prescription drug costs. Medicare's TDAPA policy has the potential to expand access to medications for patients
Dialysis (2 works) · Dialysis and Renal Disease Management (2 works) · Emergency Medicine (2 works) · Internal Medicine (2 works) · Medicine (2 works) · Business (1 works) · Calcimimetic (1 works) · Cinacalcet (1 works) · Emergency Medicine (1 works) · Family medicine (1 works)